Ad
EDIT Quote Trading Chart Editas Medicine Inc.
home / stock / edit / edit quote
Quote | Editas Medicine Inc. (NASDAQ:EDIT)
| Last: | $2.88 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $3.06 |
| Close: | $2.88 |
| High: | $3.09 |
| Low: | $2.8 |
| Volume: | 2,250,840 |
| Last Trade Date Time: | 07/11/2025 03:40:18 pm |
Quotes are delayed by 15 to 20 minutes.
EDIT Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $2.88 | $3.06 | $2.88 | $3.09 | $2.8 | 2,250,840 | 07-11-2025 |
| $3.06 | $3.115 | $3.06 | $3.18 | $2.99 | 2,562,739 | 07-10-2025 |
| $3.08 | $3.05 | $3.08 | $3.24 | $2.915 | 5,605,979 | 07-09-2025 |
| $2.86 | $2.55 | $2.86 | $3.07 | $2.535 | 5,701,604 | 07-08-2025 |
| $2.54 | $2.58 | $2.54 | $2.6267 | $2.48 | 2,142,806 | 07-07-2025 |
| $2.57 | $2.63 | $2.57 | $2.75 | $2.51 | 1,914,826 | 07-04-2025 |
| $2.57 | $2.63 | $2.57 | $2.75 | $2.51 | 1,914,826 | 07-03-2025 |
| $2.56 | $2.25 | $2.56 | $2.875 | $2.235 | 9,568,174 | 07-02-2025 |
| $2.25 | $2.16 | $2.25 | $2.3099 | $2.11 | 1,750,029 | 07-01-2025 |
| $2.2 | $2.28 | $2.2 | $2.3697 | $2.19 | 2,255,924 | 06-30-2025 |
| $2.28 | $2.15 | $2.28 | $2.33 | $2.13 | 5,462,985 | 06-27-2025 |
| $2.12 | $2.22 | $2.12 | $2.22 | $2.075 | 2,318,815 | 06-26-2025 |
| $2.19 | $2.26 | $2.19 | $2.29 | $2.14 | 2,264,927 | 06-25-2025 |
| $2.25 | $2.15 | $2.25 | $2.31 | $2.15 | 3,016,236 | 06-24-2025 |
| $2.1 | $2.185 | $2.1 | $2.24 | $2.02 | 1,787,660 | 06-23-2025 |
| $2.22 | $2.34 | $2.22 | $2.385 | $2.15 | 3,068,682 | 06-20-2025 |
| $2.35 | $2.17 | $2.35 | $2.38 | $2.05 | 3,586,557 | 06-19-2025 |
| $2.35 | $2.17 | $2.35 | $2.38 | $2.05 | 3,586,557 | 06-18-2025 |
| $2.14 | $2.31 | $2.14 | $2.55 | $2.1 | 5,458,992 | 06-17-2025 |
| $2.16 | $2.005 | $2.16 | $2.2 | $1.935 | 2,832,805 | 06-16-2025 |
News, Short Squeeze, Breakout and More Instantly...
Editas Medicine Inc. Company Name:
EDIT Stock Symbol:
NASDAQ Market:
0.0% G/L:
$2.88 Last:
2,250,840 Volume:
$3.06 Open:
$2.88 Close:
Editas Medicine Inc. Website:
Ad
-
2025-06-28 05:04:00 ET Investors looking for stocks that can produce dramatic gains in a short amount of time will want to turn their heads toward the biopharmaceutical space. Chasing short-term gains isn't the smartest way to invest, but hardly a month goes by without at least one stock fr...
-
2025-06-27 08:15:00 ET Over the past year, Editas Medicine (NASDAQ: EDIT) and Sarepta Therapeutics (NASDAQ: SRPT) , two biotech companies, have encountered severe headwinds that aren't at all related to broader market volatility. Both drugmakers have seen their shares plumme...
-
2025-06-17 10:07:00 ET The biotechnology sector is a thrilling arena for investors, with a history of delivering groundbreaking medical innovations that have led to massive shareholder returns. Editas Medicine (NASDAQ: EDIT) is a promising clinical-stage company that has captured Wa...
Important Investor News Alert (NASDAQ: CVKD)
-
LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...